TABLE 2.
Effect of copper increase on proliferation and differentiation in different cell types.
Cells | [Cu] | Features | Proliferation | Differentiation | References |
---|---|---|---|---|---|
Studies in primary cells | |||||
MSC (mesenchymal stem cells) | 50 µM Cu-His | Present in the mesodermal germinal layer | ↓ | ↑ into osteoblasts or adipocytes | Rodríguez et al. (2002) |
MEFs (Mouse embryonic fibroblasts) | 10 µM CuCl2 | Synthesize fibers and maintain matrix | ↑ | − | Itoh et al. (2008) |
HUVEC | 500 µM CuSO4 | Human umbilical vein endothelial cells | ↑ | − | Hu (1998) |
HPC (CD34+) | 10 µM CuCl2 | Hematopoietic progenitor cells | ↓ | ↑ | Peled et al. (2002); Peled et al. (2005) |
HSC | 10 µM CuCl2 | Hematopoietic stem cells | ↓ | ↑ | Huang et al. (2009) |
RIP1–Tag2 mice | 20 µM Cu via drinking water from 4 to 15 weeks of age | Tumorigenetic mouse model of pancreatic islet cell carcinoma | ↑ promotes tumor growth | − | Ishida et al. (2013) |
Astrocytes | 30 μM CuCl2 | Astroglia from rat cerebral cortex | ↑ | − | Hu et al. (2016) |
BMECs | 30–120 µM CuCl2 | Brain microvascular endothelial cells from rat | ↑ | − | Wang et al. (2016) |
Studies in cell lines from cancer | |||||
HepG2 | 64 µM CuSO4 | Human liver hepatocellular cells | ↓ | − | Aston et al. (2000); Arnal et al. (2012) |
K562 | 95 µM CuCl2 | Human erythroleukemia cell line | ↑ | ↓ | Ruiz et al. (2016) |
A-549 | 80 µM Cu | Adenocarcinomic human alveolar basal epithelial cells | ↓ | − | Arnal et al. (2012) |
HL-60 | 12 μM Cu(NO3)2 | Human promyelocytic leukemia cells | ↓ | ↑ | Bae and Percival (1993) |
Huh-7 and OUMS29 | 300 µM CuSO4 | Human hepatoma cell lines | ↓ | − | Oe et al. (2016) |
A-549 | 5–15 µM CuCl2 | Adenocarcinomic human alveolar basal epithelial cells | ↑ | − | Zhang et al. (2016) |
↑: increase; ↓: decrease.